Sun Pharma receives USFDA approval for Cerebyx
New Delhi, Mar 19 (UNI) Sun Pharmaceutical Industries Ltd today said it has received the US Food and Drug Administration approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Parke Davis's Cerebyx, fosphenytoin sodium injection.
Fosphenytoin sodium Injection has annual sales of about 15 million dollars in the US, a company statemet said.
Fosphenytoin sodium is used for the control of generalised convulsive status epilepticus as well as for prevention and treatment of seizures occurring during neurosurgery.
UNI SR MP KN1730
More From
-
India vs New Zealand T20 World Cup 2026 Final: Five Positive Signs Favouring India Before Title Clash -
IND vs NZ Final Live: When and Where to Watch India vs New Zealand T20 World Cup 2026 Title Clash -
Ind vs NZ T20 World Cup 2026: New Zealand Needs 256 Runs To Beat India And Win The World Cup -
UAE Attacks Iran, Becomes 5th Nation To Enter War; Reports Suggest Strike On Iranian Facility -
ICC T20 World Cup 2026 Final: Ricky Martin, Falguni Pathak To Perform At Closing Ceremony, How To Watch -
Who Is Nishant Kumar: Education, Personal Life and Possible Political Role -
IND vs NZ T20 WC Final: New Zealand Win Toss, Opt To Chase; Why Batting First Could Be A Tough Call For India -
Gold Rate Today 8 March 2026: IBJA Issues Fresh Gold Rates; Tanishq, Malabar, Kalyan, Joyalukkas Prices -
From Kerala Boy To World Cup Hero: Sanju Samson’s 89-Run Blitz, His Birth, Religion, Wife And Inspiring Story -
Hyderabad Gold Silver Rate Today, 8 March, 2026: Latest Gold Prices And Silver Rate In Nizam City -
Panauti Stadium? Is Narendra Modi Stadium an Unlucky Venue for India National Cricket Team? -
Storm Over West Bengal Govt's 'Snub' To President Droupadi Murmu
Click it and Unblock the Notifications
Sign in with Google